Chardan Capital Maintains Buy on Ocugen, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Chardan Capital analyst Daniil Gataulin maintains a Buy rating on Ocugen (NASDAQ:OCGN) and keeps the price target at $5.
May 15, 2024 | 2:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Chardan Capital analyst Daniil Gataulin maintains a Buy rating on Ocugen and keeps the price target at $5.
The reaffirmation of a Buy rating and a $5 price target by Chardan Capital is likely to positively impact Ocugen's stock price in the short term as it reinforces investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100